836 Results for "

PDE

" in MedChemExpress (MCE) Product Catalog:
Products (836)

836 Results for "PDE" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-B0442A
CAS No.: 224785-91-5
Vardenafil hydrochloride is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil hydrochloride shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4 . Vardenafil hydrochloride competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels . Vardenafil hydrochloride can be used for the research of erectile dysfunction, hepatitis, diabetes [1]-[6].
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0442B
CAS No.: 330808-88-3
Vardenafil hydrochloride trihydrate is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil hydrochloride trihydrate shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4 . Vardenafil hydrochloride trihydrate competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels . Vardenafil hydrochloride trihydrate can be used for the research of erectile dysfunction, hepatitis, diabetes [1]-[6].
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-17464
CAS No.: 73963-72-1
Synonyms: OPC 13013
Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A, the isoform of PDE 3 in the cardiovascular system, with an IC50 of 0.2 μM .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-14992
CAS No.: 439083-90-6
Purity:  98.24%
Synonyms: BAY 607550
Research Areas:  

Neurological Disease

Bay 60-7550 is a potent and selective PDE2 inhibitor with a Ki of 3.8 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-103160A
CAS No.: 58337-38-5
Purity:  99.67%
EHNA hydrochloride is a potent and selective dual inhibitor of cyclic nucleotide phosphodiesterase 2 (PDE2)(IC50=4 μM) and adenosine deaminase (ADA). EHNA hydrochloride exerts a concentration inhibition of the cGMP-stimulated PDE II (cGs-PDE)(IC50:0.8 μM (human), 2 μM (porcine myocardium)), but has smaller inhibitory effect on the unstimulated PDE2 activity. EHNA hydrochloride play roles in mediating diverse pharmacological responses, including antiviral, antitumour and antiarrhythmic effects .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-109586
CAS No.: 433695-36-4
Purity:  99.85%
Research Areas:  

Neurological Disease

BRL-50481 is a novel and selective inhibitor of PDE7 with IC50s of 0.15, 12.1, 62 and 490 μM for PDE7A, PDE7B, PDE4 and PDE3, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-122942
CAS No.: 56317-21-6
Purity:  98.90%
Moracin M is a phenolic component that can be isolated from Mori Cortex, is a potent phosphodiesterase-4 (PDE4) inhibitor with IC50 values of 2.9, 4.5, >40, and >100 μM for PDE4D2, PDE4B2, PDE5A1, and PDE9A2, respectively. Moracin M has anti-inflammatory activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-117571
CAS No.: 1606974-33-7
Purity:  99.50%
Synonyms: BPN14770
Research Areas:  

Neurological Disease

Zatolmilast (BPN14770) is a selective phosphodiesterase 4D (PDE4D) allosteric inhibitor with IC50s of 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3, respectively .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-W028690
CAS No.: 328104-79-6
Research Areas:  

Cancer

DNMDP, a phosphodiesterase 3A (PDE3A) inhibitor, is a potent and selective cancer cell cytotoxic agent. DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12). DNMDP shows clear cell-selective cytotoxicity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10978
CAS No.: 906673-24-3
Purity:  99.92%
Synonyms: AN-2728; PF-06930164
Research Areas:  

Inflammation/Immunology Cancer

Crisaborole (AN-2728) is a potent inhibitor of PDE4 and cytokine release; inhibit PDE4 with an IC50 of 0.49 μM.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15441
CAS No.: 1082744-20-4
Purity:  99.85%
Synonyms: PF-04447943
Research Areas:  

Neurological Disease

Edelinontrine (PF-04447943) is a potent inhibitor of human recombinant PDE9A (IC50=12 nM) with >78-fold selectivity, respectively, over other PDE family members (IC50>1000 nM).
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-145924
CAS No.: 2275774-60-0
Purity:  99.74%
Research Areas:  

Cancer

BAY 2666605 is an orally active PDE3A and PDE3B inhibitor with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 is a PDE3A-SLFN12 complex inducer (WO2019025562A1; example 135) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10790
CAS No.: 153259-65-5
Purity:  99.91%
Synonyms: SB-207499
Research Areas:  

Inflammation/Immunology

Cilomilast (SB-207499) is a potent, selective and orally active inhibitor of Phosphodiesterase 4 (PDE4), with IC50s of ~100 and 120 nM for LPDE4 and HPDE4, respectively. Cilomilast shows selectivity for PDE4 over PDE1, PDE2, PDE3 and PDE5 (IC50=74, 65, >100, and 83 μM, respectively). Cilomilast has anti-inflammatory and immunomodulatory effects and can be used for thr research of asthma and chronic obstructive pulmonary disease (COPD) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12501A
CAS No.: 1642303-38-5
Purity:  99.19%
Research Areas:  

Neurological Disease

ITI-214 is a potent, CNS-active, orally bioavailable PDE1 inhibitor (Ki of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 inhibits recombinant full-length human PDE1A, PDE1B and PDE1C with Kis of 33 pM, 380 pM and 35 pM, respectively. ITI-214 shows efficacy in various animal models of motor and cognitive functions .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-50098
CAS No.: 898562-94-2
Synonyms: PF-2545920
Research Areas:  

Neurological Disease Cancer

Mardepodect is a potent, selective orally active, and brain-penetrant PDE10A inhibitor with an IC50 of 0.37 nM, with >1000-fold selectivity over other PDEs .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-50098A
CAS No.: 2070014-78-5
Synonyms: PF-2545920 hydrochloride
Research Areas:  

Cancer

Mardepodect hydrochloride (PF-2545920 hydrochloride) is a potent, orally active and selective PDE10A inhibitor with an IC50 of 0.37 nM, with >1000-fold selectivity over other PDEs. Mardepodect hydrochloride can cross the blood-brain barrier .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0327A
CAS No.: 84504-69-8
Synonyms: Dicloguamine maleate; MN1695
Research Areas:  

Inflammation/Immunology

Irsogladine is a PDE4 inhibitor and muscarinic acetylcholine receptor binder.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0204
CAS No.: 74150-27-9
Synonyms: UD-CG115
Research Areas:  

Cardiovascular Disease

Pimobendan (UD-CG115) is a selective inhibitor of PDE3 with IC50 of 0.32 μM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-128879A
CAS No.: 1281681-33-1
Purity:  98.01%
VP3.15 dihydrobromide is a highly potent, orally bioavailable, and CNS-penetrant PDE7-GSK3 dual inhibitor, with IC50 values of 1.59 μM and 0.88 μM against PDE7 and GSK3, respectively . VP3.15 dihydrobromide elevates intracellular cAMP levels, suppresses immune responses, enhances remyelination, limits excessive tau phosphorylation, and alleviates neuroinflammation and neuronal loss. VP3.15 dihydrobromide promotes oligodendrocyte precursor cell differentiation, improves in vivo remyelination, inhibits autoimmune encephalomyelitis, and mitigates germinal matrix-intraventricular hemorrhage-related brain injury, cerebral atrophy, ventricular enlargement, and cognitive impairment. VP3.15 dihydrobromide can be used in research related to multiple sclerosis and germinal matrix-intraventricular hemorrhage .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-109085
CAS No.: 937782-05-3
Purity:  99.63%
Synonyms: OPA-15406
Difamilast (OPA-15406) is a topical, selective and nonsteroidal phosphodiesterase-4 (PDE4) inhibitor with particularly efficient inhibition of subtype B (IC50=11.2 nM). Difamilast can be used for the research of mild to moderate atopic dermatitis (AD) .
loading...
    loading...